Product Details
What is this medicine used for?
· For the treatment of the following infections caused by susceptible microorganisms:
- Upper respiratory tract infections including streptococcal pharyngitis and tonsillitis
- Acute otitis media and acute maxillary sinusitis
- Lower respiratory tract infections including atypical pneumonia, bronchitis
- Skin and skin structure infections including impetigo, folliculitis, cellulitis, abscesses (abscesses usually require surgical drainage)
- Disseminated or localized mycobacterial infections due to Mycobacteriumintracellulare or Mycobacterium avium. Localized infections due to Mycobacteriumkansasii, Mycobacteriumchelonae and Mycobacterium fortuitum(usually in combination with other antimicrobial agents)
- Helicobacter pylori infections (in combination with other drugs)
- Odontogenic infections
How much and how often should you use this medicine?
Usual Recommended Oral Adult Dose:
Serious Infections: 150 mg to 300 mg every 6 hours
More Severe Infections: 300 mg to 450 mg every 6 hours
Or, as prescribed by a physician.
Recommended Oral Adult Dose for Specific Infections:
|
Infection |
Recommended Oral Clindamycin Dose |
Duration of Treatment |
|
Acne |
150 mg every 12 hours |
- |
|
Bacterial vaginosis |
300 mg every 12 hours |
7 days |
|
Cervicitis due to Chlamydia trachomatis |
450 mg every 6 hours |
10 to 14 days |
|
Pelvic Inflammatory Disease (Inpatient Treatment) |
Initially with intravenous (IV) therapy (Clindamycin IV 900 mg every 8 hours plusan IV antibiotic with an appropriate Gram-negative aerobic spectrum) for at least 4 days and at least 48 hours after the patient improves. Then continue with oral clindamycin hydrochloride 450 mg every 6 hours to complete duration of treatment. |
10 to 14 days |
|
Prevention of Bacterial Endocarditis in penicillin-allergic patients |
600 mg, one (1) hour before the procedure |
single dose |
|
Pneumocystis jiroveci (carinii) pneumonia in patients with |
Primaquine |
21 days
Note: If the patient should develop serious hematologic adverse effects, the dosage regimen of primaquine and/or clindamycin should be reduced. |
|
|
|
|
|
Alternative treatment of multi-drug resistant Plasmodium falciparum infection** |
20 mg/kg/day divided in three (3) equal doses
+
Quinine or Amodiaquine |
At least 5 days |
|
Or, as prescribed by a physician. |
||
Contraindications
- Hypersensitivity to Clindamycin or any ingredient in the product
Availability
- Clindamycin 150 mg Tablet – Box of 100’s (in blister foil by 10’s)
- Clindamycin 300 mg Tablet – Box of 100’s (in blister foil by 10’s)
